149 related articles for article (PubMed ID: 15177446)
1. Exploration of the P2-P3 SAR of aldehyde cathepsin K inhibitors.
Boros EE; Deaton DN; Hassell AM; McFadyen RB; Miller AB; Miller LR; Paulick MG; Shewchuk LM; Thompson JB; Willard DH; Wright LL
Bioorg Med Chem Lett; 2004 Jul; 14(13):3425-9. PubMed ID: 15177446
[TBL] [Abstract][Full Text] [Related]
2. Exploration of the P1 SAR of aldehyde cathepsin K inhibitors.
Catalano JG; Deaton DN; Furfine ES; Hassell AM; McFadyen RB; Miller AB; Miller LR; Shewchuk LM; Willard DH; Wright LL
Bioorg Med Chem Lett; 2004 Jan; 14(1):275-8. PubMed ID: 14684342
[TBL] [Abstract][Full Text] [Related]
3. Trifluoroethylamines as amide isosteres in inhibitors of cathepsin K.
Black WC; Bayly CI; Davis DE; Desmarais S; Falgueyret JP; Léger S; Li CS; Massé F; McKay DJ; Palmer JT; Percival MD; Robichaud J; Tsou N; Zamboni R
Bioorg Med Chem Lett; 2005 Nov; 15(21):4741-4. PubMed ID: 16154747
[TBL] [Abstract][Full Text] [Related]
4. Potent and selective P2-P3 ketoamide inhibitors of cathepsin K with good pharmacokinetic properties via favorable P1', P1, and/or P3 substitutions.
Barrett DG; Catalano JG; Deaton DN; Hassell AM; Long ST; Miller AB; Miller LR; Shewchuk LM; Wells-Knecht KJ; Willard DH; Wright LL
Bioorg Med Chem Lett; 2004 Oct; 14(19):4897-902. PubMed ID: 15341947
[TBL] [Abstract][Full Text] [Related]
5. Solid-phase parallel synthesis and SAR of 4-amidofuran-3-one inhibitors of cathepsin S: effect of sulfonamides P3 substituents on potency and selectivity.
Ayesa S; Lindquist C; Agback T; Benkestock K; Classon B; Henderson I; Hewitt E; Jansson K; Kallin A; Sheppard D; Samuelsson B
Bioorg Med Chem; 2009 Feb; 17(3):1307-24. PubMed ID: 19124252
[TBL] [Abstract][Full Text] [Related]
6. Keto-1,3,4-oxadiazoles as cathepsin K inhibitors.
Palmer JT; Hirschbein BL; Cheung H; McCarter J; Janc JW; Yu ZW; Wesolowski G
Bioorg Med Chem Lett; 2006 Jun; 16(11):2909-14. PubMed ID: 16546382
[TBL] [Abstract][Full Text] [Related]
7. Novel, potent P2-P3 pyrrolidine derivatives of ketoamide-based cathepsin K inhibitors.
Barrett DG; Catalano JG; Deaton DN; Hassell AM; Long ST; Miller AB; Miller LR; Ray JA; Samano V; Shewchuk LM; Wells-Knecht KJ; Willard DH; Wright LL
Bioorg Med Chem Lett; 2006 Mar; 16(6):1735-9. PubMed ID: 16376075
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and SAR of arylaminoethyl amides as noncovalent inhibitors of cathepsin S: P3 cyclic ethers.
Tully DC; Liu H; Chatterjee AK; Alper PB; Epple R; Williams JA; Roberts MJ; Woodmansee DH; Masick BT; Tumanut C; Li J; Spraggon G; Hornsby M; Chang J; Tuntland T; Hollenbeck T; Gordon P; Harris JL; Karanewsky DS
Bioorg Med Chem Lett; 2006 Oct; 16(19):5112-7. PubMed ID: 16876402
[TBL] [Abstract][Full Text] [Related]
9. 2-Cyano-pyrimidines: a new chemotype for inhibitors of the cysteine protease cathepsin K.
Altmann E; Aichholz R; Betschart C; Buhl T; Green J; Irie O; Teno N; Lattmann R; Tintelnot-Blomley M; Missbach M
J Med Chem; 2007 Feb; 50(4):591-4. PubMed ID: 17256925
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of dipeptide alpha-keto-beta-aldehydes as new inhibitors of cathepsin S.
Walker B; Lynas JF; Meighan MA; Brömme D
Biochem Biophys Res Commun; 2000 Aug; 275(2):401-5. PubMed ID: 10964677
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 1.
Liu H; Tully DC; Epple R; Bursulaya B; Li J; Harris JL; Williams JA; Russo R; Tumanut C; Roberts MJ; Alper PB; He Y; Karanewsky DS
Bioorg Med Chem Lett; 2005 Nov; 15(22):4979-84. PubMed ID: 16183279
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and SAR of succinamide peptidomimetic inhibitors of cathepsin S.
Chatterjee AK; Liu H; Tully DC; Guo J; Epple R; Russo R; Williams J; Roberts M; Tuntland T; Chang J; Gordon P; Hollenbeck T; Tumanut C; Li J; Harris JL
Bioorg Med Chem Lett; 2007 May; 17(10):2899-903. PubMed ID: 17382545
[TBL] [Abstract][Full Text] [Related]
13. Azepanone-based inhibitors of human cathepsin S: optimization of selectivity via the P2 substituent.
Kerns JK; Nie H; Bondinell W; Widdowson KL; Yamashita DS; Rahman A; Podolin PL; Carpenter DC; Jin Q; Riflade B; Dong X; Nevins N; Keller PM; Mitchell L; Tomaszek T
Bioorg Med Chem Lett; 2011 Aug; 21(15):4409-15. PubMed ID: 21733692
[TBL] [Abstract][Full Text] [Related]
14. Ketoamide-based inhibitors of cysteine protease, cathepsin K: P3 modifications.
Tavares FX; Deaton DN; Miller LR; Wright LL
J Med Chem; 2004 Oct; 47(21):5057-68. PubMed ID: 15456249
[TBL] [Abstract][Full Text] [Related]
15. Arylaminoethyl carbamates as a novel series of potent and selective cathepsin S inhibitors.
Tully DC; Liu H; Chatterjee AK; Alper PB; Williams JA; Roberts MJ; Mutnick D; Woodmansee DH; Hollenbeck T; Gordon P; Chang J; Tuntland T; Tumanut C; Li J; Harris JL; Karanewsky DS
Bioorg Med Chem Lett; 2006 Oct; 16(19):5107-11. PubMed ID: 16876407
[TBL] [Abstract][Full Text] [Related]
16. Potent and selective ketoamide-based inhibitors of cysteine protease, cathepsin K.
Tavares FX; Deaton DN; Miller AB; Miller LR; Wright LL; Zhou HQ
J Med Chem; 2004 Oct; 47(21):5049-56. PubMed ID: 15456248
[TBL] [Abstract][Full Text] [Related]
17. 3D-QSAR and docking studies of aldehyde inhibitors of human cathepsin K.
Pan X; Tan N; Zeng G; Han H; Huang H
Bioorg Med Chem; 2006 Apr; 14(8):2771-8. PubMed ID: 16377193
[TBL] [Abstract][Full Text] [Related]
18. Semicarbazone-based inhibitors of cathepsin K, are they prodrugs for aldehyde inhibitors?
Adkison KK; Barrett DG; Deaton DN; Gampe RT; Hassell AM; Long ST; McFadyen RB; Miller AB; Miller LR; Payne JA; Shewchuk LM; Wells-Knecht KJ; Willard DH; Wright LL
Bioorg Med Chem Lett; 2006 Feb; 16(4):978-83. PubMed ID: 16290936
[TBL] [Abstract][Full Text] [Related]
19. Beta-substituted cyclohexanecarboxamide cathepsin K inhibitors: modification of the 1,2-disubstituted aromatic core.
Robichaud J; Bayly CI; Black WC; Desmarais S; Léger S; Massé F; McKay DJ; Oballa RM; Pâquet J; Percival MD; Truchon JF; Wesolowski G; Crane SN
Bioorg Med Chem Lett; 2007 Jun; 17(11):3146-51. PubMed ID: 17408953
[TBL] [Abstract][Full Text] [Related]
20. Novel scaffold for cathepsin K inhibitors.
Teno N; Miyake T; Ehara T; Irie O; Sakaki J; Ohmori O; Gunji H; Matsuura N; Masuya K; Hitomi Y; Nonomura K; Horiuchi M; Gohda K; Iwasaki A; Umemura I; Tada S; Kometani M; Iwasaki G; Cowan-Jacob SW; Missbach M; Lattmann R; Betschart C
Bioorg Med Chem Lett; 2007 Nov; 17(22):6096-100. PubMed ID: 17911019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
